Lupus & Connective Tissue Diseases
Latest News
Meet the Pregnancy Challenges of Women With Chronic Conditions
Proactive disease management and lifestyle modifications before and during pregnancy can improve maternal and infant health for women with...
From the Journals
Women’s Risk for Lupus Rises With Greater Intake of Ultraprocessed Foods
The risk for SLE doubled in women with anti–double-stranded DNA antibodies.
From the Journals
Sustained Low Lupus Disease Activity May Give Lower Risk for Flares, Organ Damage
Achievement of a sustained low disease activity state for ≥ 3 months protected against damage accrual and flares in patients with SLE in a large...
Conference Coverage
CAR T-Cell Treatment Data Expands in Refractory Rheumatic Diseases, Demonstrating Consistent Efficacy
Numerous cases and case series presented at EULAR 2024 add to a rapidly growing collection of evidence that CAR T-cell therapy will be a...
From the Journals
Form of B12 Deficiency Affecting the Central Nervous System May Be New Autoimmune Disease
The findings uncover “yet another example of a disease where antibodies getting into the brain are the problem.”
Guidelines
‘Therapeutic Continuums’ Guide Systemic Sclerosis Treatment in Updated EULAR Recommendations
The recommendations highlighted the use of immunosuppressive agents and antifibrotics to treat skin fibrosis and lung fibrosis, as well as changes...
From the Journals
Low Hydroxychloroquine Levels in Early Pregnancy Tied to Greater Flares in SLE
Hydroxychloroquine levels are linked to maternal flares in SLE, but not to adverse pregnancy outcomes.
From the Journals
Sex-Related Differences Found in IgG4-Related Disease Epidemiology
A recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Conference Coverage
Autoantibodies Nonspecific to Systemic Sclerosis May Play Role in ILD Prediction
Anti-Ro/SSA antibodies predicted which patients were at most risk for ILD but not ILD progression or overall disease progression and death.
Conference Coverage
Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis
Results from the SELECT-GCA study showed that upadacitinib (Rinvoq) induced significant and sustained remission in people with new-onset or...
Conference Coverage
EULAR 2024 Preview: Therapeutics in Development Take Center Stage
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in...